Changing characteristics of patients with vasospastic angina in the era of new calcium channel blockers

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 4, 2004, Pages 480-485

  Ito, Akira ^a   Fukumoto, Yoshihiro ^a   Shimokawa, Hiroaki ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Benidipine; Calcium blockers; Coronary artery spasm; Prognosis

Indexed keywords

AMLODIPINE; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SMOKING; SURVIVAL; TREATMENT OUTCOME; VASOSPASM; VASOSPASTIC ANGINA;

ADMINISTRATION, SUBLINGUAL; ADULT; AGED; AGED, 80 AND OVER; AMLODIPINE; ANGINA PECTORIS, VARIANT; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; DIABETES COMPLICATIONS; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; PROGNOSIS; SMOKING; SURVIVAL RATE; VASODILATOR AGENTS;

EID: 4644359796     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000141473.29254.62     Document Type: Article

References (16)

1. Mohri M, Shimokawa H, Takeshita A. Coronary artery spasm: Clinical aspects. In: Lanzer P, Topol EJ, eds. Panvascular Medicine. Integrated Clinical Management. Heidelberg, Germany: Springer-Verlag; 2002:921-930.
2. Severi S, Davies G, Maseri A, et al. Long-term prognosis of "variant" angina with medical treatment. Am J Cardiol. 1980;46:226-232.
3. Waters DD, Szlachcic J, Miller D, et al. Clinical characteristics of patients with variant angina complicated by myocardial infarction or death within one month. Am J Cardiol. 1982;49:658-664.
4. Waters DD, Miller D, Szlachcic J, et al. Factors influencing the long-term prognosis of treated patients with variant angina. Circulation. 1983;68:258-265.
5. Mark DB, Califf RM, Morris KG, et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation. 1984;69:880-888.
6. Nakamura M, Takeshita A, Nose Y. Clinical characteristics associated with myocardial infarction, arrhythmias, and sudden death in patients with vasospastic angina. Circulation. 1987;75:1110-1116.
7. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina. A comparative study between western and Japanese populations. Int J Cardiol. 1988;18:331-349.
8. Maier-Lenz H, Rode H, Lenau H, et al. Benidipine hydrochloride-a new calcium-channel blocker of the dihydropyridine type. Pharmacokinetics, pharmacodynamics, tolerance and dose finding in mild to moderate hypertension. Arzneimittelforschung. 1988;38:1757-1763.
9. Chahine RA, Feldman RL, Giles TD, et al. Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160. Am Heart J. 1989;118:1128-1130.
10. Karasawa A, Kubo K. Calcium antagonistic effects an the in vitro duration of actions of KW-3049, a new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol. 1988;47:35-44.
11. Moriyama T, Karasawa A. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs. Biol Pharm Bull. 1994;17:1468-1471.
12. Karasawa A, Kubo K, Shuto K, et al. Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study. Arzneimittelforschung. 1988;38:1702-1707.
13. Nakamura Y, Moss AJ, Brown MW, et al. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J. 1999;13:577-585.
14. Hirai N, Kawano H, Yasue H, et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation. 2003;108:1446-1450.
15. Chutkow WA, Pu J, Wheeler MT, et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J Clin Invest. 2002;110:203-208.
16. Shinozaki K, Suzuki M, Ikebuchi M, et al. Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation. 1995;92:1749-1757.